Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE‐LY Trial
Background Cardiac biomarkers and left ventricular hypertrophy (LVH) are related to the risk of stroke and death in patients with atrial fibrillation. We investigated the interrelationship between LVH and cardiac biomarkers and their independent associations with outcomes. Methods and Results Plasma...
| Հիմնական հեղինակներ: | , , , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
Wiley
2019-01-01
|
| Շարք: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://www.ahajournals.org/doi/10.1161/JAHA.118.010107 |